FIELD: chemistry.
SUBSTANCE: present invention relates to a method for producing hydroxamic acids, derivatives of 2-aryl-2.3-dihydroquinazolin-4(1H)-s, containing hydroxamic acid, which can be used in medicine for the treatment of various diseases by inhibiting histone deacetylases. Disclosed is a method for producing hydroxamic acids, derivatives of 2-aryl-2.3-dihydroquinazolin-4(1H)-s, having the following general formula, where R is hydrogen or halogen; R1, R2, R3 independently of each other are hydrogen, halogen, OMe where R4 is halogen at the 2nd, 3rd or 4th position of the phenyl ring; n = 4, 5. The proposed method of obtaining compounds is carried out using derivatives of hydroxamic acid as starting compounds, namely 2-amino-N-(6-(hydroxyamino) -6-oxohexyl) benzamide, 2-amino-N- (7 -(hydroxyamino) -7-oxoheptyl) benzamide or 2-amino-5-fluoro-N- (7- (hydroxyamino) -7-oxoheptyl) -benzamide, to solutions of which in tetrahydrofuran in an argon atmosphere is added a solution of substituted benzaldehyde in tetrahydrofuran in molar ratio of hydroxamic acid derivative to benzaldehyde 1: 1.1, after which the reaction mixture was stirred at room temperature for 2-3 hours, the solvent was removed in vacuum, diethyl ether was added to the residue, the crystals formed were filtered off, washed with diethyl ether and dried. The activity of a number of compounds towards the HDAC1 and HDAC6 enzymes exceeds the activity of the known histone deacetylase inhibitor Vorinostat (SAHA).
EFFECT: invention helps to obtain hydroxamic acids, derivatives of 2-aryl-2.3-dihydroquinazolin-4(1H)-s.
1 cl, 16 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING N-((HYDROXYAMINO)-OXOALKYL)-2-(QUINAZOLIN-4-YLAMINO)-BENZAMIDES | 2019 |
|
RU2722694C1 |
HYDROXAMIC ACIDS, DERIVATIVES OF 4-AMINOQUINAZOLINE-7-CARBOXYLIC ACID AS INHIBITORS OF HISTONE DEACETYLASE, AND METHOD FOR SYNTHESIS THEREOF | 2021 |
|
RU2779981C1 |
3-HYDROXYQUINAZOLINE-4(3H)-ONE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS AND A METHOD FOR PRODUCTION THEREOF | 2020 |
|
RU2740503C1 |
ARYLCYCLOALKYLAMINES DERIVATIVES NEUROPROTECTOR (VERSIONS), SUBSTANCES WITH COMBINED NEUROPROTECTOR, ANALGETIC AND ANTIDEPRESSIVE ACTION, PHARMACEUTICAL COMPOSITIONS BASED THEREON | 2016 |
|
RU2637928C2 |
DERIVATIVES OF 2-(IMINOMETHYL)AMINOPHENYL, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND INTERMEDIATE COMPOUNDS | 1998 |
|
RU2183211C2 |
HISTONES DEACETYLASES (HDACS) INHIBITORS | 2013 |
|
RU2629947C2 |
QUINOLYL-CONTAINING COMPOUND OF HYDROXAMIC ACID, METHOD FOR THEREOF OBTAINING AND APPLICATION IN TREATMENT OF DISEASES, CAUSED BY ABNORMAL PROTEINKINASE AND/OR HYSTONE DEACETYLASE ACTIVITY | 2011 |
|
RU2573633C2 |
HISTONE DEACETYLASE INHIBITORS | 2008 |
|
RU2453536C2 |
NOVEL 4-AMINO-N-HYDROXYBENZAMIDES AS HDAC INHIBITORS FOR TREATING CANCER | 2012 |
|
RU2591190C2 |
HETEROCYCLIC ALKYL DERIVATIVE COMPOUNDS AS THE HISTONE DEACETYLASE SELECTIVE INHIBITORS AND CONTAINING THEM PHARMACEUTICAL COMPOSITIONS | 2016 |
|
RU2683022C1 |
Authors
Dates
2021-03-15—Published
2020-06-25—Filed